NORTHERN TRUST CORP - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 88 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,761,370
-21.0%
323,187
-1.6%
0.00%
Q2 2023$2,230,665
+47.3%
328,522
+8.7%
0.00%
Q1 2023$1,514,668
-3.1%
302,329
-5.6%
0.00%
Q4 2022$1,563,605
-67.0%
320,411
-2.6%
0.00%
-100.0%
Q3 2022$4,745,000
-5.8%
329,023
-1.2%
0.00%0.0%
Q2 2022$5,039,000
+29.6%
333,098
+1.8%
0.00%0.0%
Q1 2022$3,888,000
-30.3%
327,253
-4.9%
0.00%0.0%
Q4 2021$5,576,000
-43.7%
343,987
-0.9%
0.00%
-50.0%
Q3 2021$9,904,000
-15.4%
347,034
+0.2%
0.00%0.0%
Q2 2021$11,709,000
+12.0%
346,406
+0.2%
0.00%0.0%
Q1 2021$10,457,000
-40.2%
345,801
-2.1%
0.00%
-33.3%
Q4 2020$17,483,000
+21.7%
353,099
-5.6%
0.00%0.0%
Q3 2020$14,365,000
-12.3%
374,196
-1.3%
0.00%
-25.0%
Q2 2020$16,384,000
+111.7%
379,256
+27.9%
0.00%
+100.0%
Q1 2020$7,738,000
-14.3%
296,486
+2.6%
0.00%0.0%
Q4 2019$9,029,000
+40.1%
288,898
+16.8%
0.00%0.0%
Q3 2019$6,446,000
+147.2%
247,326
+116.9%
0.00%
+100.0%
Q2 2019$2,608,000
+22.1%
114,023
+39.9%
0.00%0.0%
Q1 2019$2,136,000
+39.3%
81,492
+8.2%
0.00%
Q4 2018$1,533,00075,3290.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders